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E-mail address: Chuantao.jiang@uth.tmc.edu (C. JiSubstantial evidence implicates that the aggregation of a-synuclein (aSyn) is a critical factor in the
pathogenesis of Parkinson’s disease. This study focuses on the role of aSyn C-terminus. We intro-
duced two additional cysteine residues at positions 107 and 124 (A107C and A124C) to our previous
construct. Five X-isomers of oxidative-folded mutation of a-synuclein with three disulﬁdes were
isolated and their secondary structures and aggregating features were analyzed. All isomers showed
similar random coil structures as wild-type a-synuclein. However, these isomers did not form aggre-
gates or ﬁbrils, even with prolonged incubation, suggesting that the interactions between the C-ter-
minal and N-terminal or central NAC region are important in maintaining the natively unfolded
structure of aSyn and thus prevent aSyn from changing conformation, which is a critical step for
ﬁbrillation.
Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Misfolded proteins and the resulting aggregation cause cellular
dysfunction and even cell death. The misfolding of more than 20
proteins has been evidenced to be associated with amyloid ﬁbril
diseases [1–3]. In fact, it is suggested that the ability to form ﬁbrils
may be a generic property of the polypeptide backbone, although
the propensities of different sequences to form such species can
differ widely [4–6]. Most neurodegenerative diseases, such as Alz-
heimer’s, Prion and Parkinson’s disease (PD), are well known
examples of amyloid ﬁbril diseases.
In PD patients, ﬁbrils of a-synuclein (aSyn) are observed in
Lewy bodies, which is the cardinal hallmark of PD pathology [7].
aSyn is an abundant brain protein of 140 residues, lacking both
cysteine and tryptophan residues, and belongs to the family of
intrinsically disordered (or natively unfolded) proteins [8–10].
aSyn is present in high concentration at presynaptic terminals as
soluble or membrane-associated fractions. Linkage studies have
shown that three independent missense mutations (A30P, E46K,lf of the Federation of European Bi
P-HPLC, reverse phase high
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ang).and A53T) within the aSyn gene can lead to rare familial forms
of early onset PD [11,12] and aSyn gene triplication was identiﬁed
in two independent families. [13–16]. Both aSyn transgenic mice
and ﬂies result in motor deﬁcits and neuronal inclusions reminis-
cent of PD [17–19]. These studies conclude that both mutations
of aSyn and an increase of cellular aSyn expression are critical
steps in the pathogenesis of PD [20].
Thermodynamically, the natively unfolded aSyn must comprise
a mixture of heterogeneous conformational isomers that exist in a
state of equilibrium. In this equilibrium model, it is generally be-
lieved that any shift of the equilibrium toward isomers of aSyn
with a highly aggregative propensity would trigger or initiate the
process of synucleinopathies. The structure of aSyn can be divided
into three regions: residues 1–60, which contain four 11-amino
acid imperfect repeats (coding for amphipathic helices) with a con-
sensus motif (KTKEGV); residues 61–95, which contain the amyloi-
dogenic NAC region [21] and two additional repeats; and residues
96–140, which is the highly charged C-terminal region. A number
of studies have elucidated the roles of each region on the ﬁbrilla-
tion of aSyn. The NAC (non-amyloid b component) region com-
prises the hydrophobic core of the protein and has been shown
to form a core region of the protoﬁlaments and ﬁbrils of aSyn
[21,22]. The N-terminus interacts with acidic phospholipids, which
may transform it into a helical conformation [23–25]. The acidic C-
terminus does not seem to play a key role in the ﬁbrillation of
aSyn. Instead, it maintains the natively unfolded structure of aSyn
[26] through ﬁbril maturation induced by interaction between the
protoﬁlaments [22].ochemical Societies.
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(S9C, S42C, A69C, and A89C) formed three stable aSyn isomers
(2SS) depending on the disulﬁde combinations [27]. All three iso-
mers exhibited a similar propensity for forming ﬁbrils as wild-type
a-synuclein (wt-aSyn), though they showed more a-helical con-
formation. The stabilized and isolated conformational isomers are
very useful for further structural and functional evaluation. In this
study, we sought to understand the role of the C-terminus on the
structural and functional properties of aSyn. We created novel
aSyn mutants by replacing six residues (Ser9, Ser42, Ala69,
Ala89, Ala107, and Ala124) with cysteine. Our results indicated
that aSyn isomers (3SS) show similar unfolded structures as wt-
aSyn, but they do not form aggregates and ﬁbrils even with pro-
longed incubation.2. Materials and methods
2.1. Site-directed mutagenesis of human aSyn
The aSyn mutants S9C/S42C/A69C/A89C/A107C and A124C
were created using the pRK172/human aSyn plasmid via the Quik-
Change method (Stratagen, La Jolla, CA).
2.2. Expression and puriﬁcation of wt and mutant aSyn from
Escherichia coli BL21
Expression and puriﬁcation of human recombinant wt-aSyn
and mutants were performed as previously described [28]. To im-
prove purity, we added another puriﬁcation step with reverse-
phase HPLC. Mutant aSyn proteins were reduced and denatured
in Tris–HCl (0.1 M, pH 8.4) containing 8 M Urea and 30 mM dithi-
othreitol, before purifying from reverse phase high performance li-
quid chromatography (RP-HPLC). Such preparations ensues us with
the starting material to generate the aSyn isomers. Matrix-assisted
laser desorption ionization (MALDI) mass spectrometer (Perkin–El-
mer Voyager-DE STR) veriﬁed the molecular mass and protein pur-
ity after expression. Puriﬁed protein was lyophilized and stored at
20 C. Protein concentration was determined by BCA assay.
2.3. Analysis of oxidative folding of aSyn(6C) mutant
Oxidative folding of fully reduced mutation of a-synuclein with
six Cys residues [aSyn(6C)] was performed by dissolving in Tris–
HCl (0.1 M, pH 8.4) alone or in the presence of 2 lM CuSO4. The
concentration of protein was 0.1 mg/ml. Folding intermediates
were trapped in a time course manner by mixing aliquots of the
sample with an equal volume of aqueous quenching buffer (4%
TFA, 20% acetonitrile) and analyzed directly by RP-HPLC. The col-
umn was a Zorbax 300XB-C18, 250 mm  4.6 mm, 5 lm model.
Buffer A was 0.1% TFA in water and buffer B was 0.086% TFA in a
9/1 acetonitrile/water mixture (by volume). The gradient of elution
was linear from 30% to 60% B over 45 min. The ﬂow rate was
0.5 ml/min.
2.4. Thioﬂavin T ﬁbrillation assay
Measurement of ﬁbrillation kinetics was carried out by moni-
toring ﬂuorescence during protein ﬁbrillation in the presence of
ThT, which shows increased ﬂuorescence when binding to amyloid
ﬁbrils [29,30]. The ﬂuorescence was monitored using an excitation
of 450 nm and measuring the emission at 485 nm. Samples
(0.5 mg/ml) were dissolved in buffer containing 100 mM NaCl,
50 mM sodium phosphate buffer (pH 7.5), 10 lM ThT. Multiple
samples were assayed using 96-well plate (Black plastic, clear bot-
tom). A Teﬂon bead (1/8 in diameter; LabPure, Saint-Gobain) wasadded to each well. Plates were then sealed and monitored with
a ﬂuorescence plate reader (BioTek, FLx800) at 37 C with shaking.
2.5. Cross-seeding experiments
Sonicated ﬁbril of aSyn was used as a seed in cross-seeding
experiments. Seed of wt aSyn was prepared as follows: a solution
of ﬁbrils was centrifuged at 13200 rpm for 30 min. After removal of
supernatant, the pellet was suspended in 100 mM NaCl, 50 mM so-
dium phosphate buffer, pH 7.5, and mildly sonicated. The effect of
cross-seeding on the ﬁbrillation of the X-isomers was studied by
adding 10% (w/w) of the seeds.
2.6. Circular dichroism measurements
CD spectra were obtained with a Jasco spectropolarimeter
(J-715). Spectra were recorded in a 0.1 cm path length round cell
from 250 to 190 nm. For all spectra, an average of 20 scans was
obtained. CD spectrum of the appropriate buffer was recorded
and served as control.
2.7. Western blotting
X-isomers for the ﬁbrillation experiments were harvested for
Western blotting. After centrifugation, the supernatant protein
were mixed 1:1 with loading buffer, run in SDS page gel, and trans-
ferred to nitrocellulose membrane. The membranes were blocked
with 5% nonfat dry milk in PBST for 1 h at room temperature, fol-
lowed by overnight incubation with mouse anti-human aSyn
monoclonal antibody (abcam, Cambridge, MA) at 4 C. After PBS
washes, the membrane was incubated with HRP conjugated anti-
mouse secondary antibody for 1 h at room temperature. The sig-
nals were detected using the enhanced chemiluminescence assay
(Pierce ECL, Thermo Scientiﬁc Co.).3. Results
3.1. Oxidative folding of aSyn(6C)
One of the best methods to isolate and characterize X-isomers
with disulﬁde scrambling of proteins is RP-HPLC [31,32] owing to
the different hydrophobic properties of conformational X-isomers.
The oxidative folding of fully reduced aSyn(6C) was monitored as a
function of time by using RP-HPLC. aSyn(6C) dissolved well in
Tris–HCl buffer (0.1 M, pH 8.4) and immediately folded without
any denaturant. During folding, the HPLC proﬁles showed many
intermediate isomers with one or two disulﬁde bonds (Fig. 2A).
In contrast with mutation of a-synuclein with four Cys residues
[aSyn(4C)] folding, aSyn(6C) showed more intermediate species
because of more disulﬁde bond combinations and consequently
taking longer to become fully folded isomers containing three
disulﬁde bonds [aSyn(3SS)] [27]. We could get 15 different
aSyn(3SS) isomers theoretically (Fig. 1), but the ﬁnal HPLC proﬁle
showed ﬁve major peaks and some small peaks. These ﬁve peaks
which we termed isomers a, b, c, d, and e were collected for further
studies (Fig. 2A). We also examined the free thiol groups in X-iso-
mers using 4-vinylpyridine reaction [33] and checked the molecu-
lar weight with MALDI mass spectrometer. All X-isomers had no
free thiol group (data not shown). We next studied the effect of
copper ion on the oxidative folding of aSyn(6C). Copper ions are
known to catalyze air oxidation of thiol groups to disulﬁde bonds
[34]. The presence of 2 lM CuSO4 accelerated the folding rate of
aSyn(6C) (Fig. 2B), consistent with its effect on aSyn(4C) folding
[27]. On the basis of RP-HPLC proﬁles, the formation of aSyn(3SS)
isomers were compared as the UV intensity of each isomer’s peaks
Fig. 2. Oxidative folding of wt-aSyn(6C). The fully reduced aSyn(6C) was allowed to refold (A) in Tris–HCl buffer (0.1 M, pH 8.4) and (B) in the presence of 2 lM CuSO4. Wt-
aSyn exhibit the same elution time as that of reduced wt-aSyn(6C).
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Fig. 1. Amino acid sequential scheme of expected X-isomers of aSyn(3SS) induced by different combinations of the disulﬁde bonds.
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close to the other intermediates’, as such isomer-e was not plotted
due to its inaccurate values. At the start of oxidative folding, the re-
duced aSyn(6C) was decreased with the formation of some folding
intermediates, however, the formation of X-isomers need a lag
phase, in which they experience certain states of folding interme-
diates (Fig. 3A). In order to compare directly, those kinetic data
were normalized in Fig. 3B. Intriguingly, all isomers formed simul-
taneously, suggesting that these X-isomers exist in a state of equi-
librium. Because aSyn(6C) is not a natural protein, the formation of
disulﬁde bonds between close Cys residues might be the rate-lim-
iting step in the oxidative folding of aSyn(6C).
3.2. Secondary structure analysis by far-UV CD spectra
The secondary structure of isolated X-isomers was examined
using far-UV CD. Wt-aSyn is a natively unfolded protein and exhib-
its random coil structure under physiological conditions. Interest-
ingly, the CD spectra of all ﬁve X-isomers showed the same
random coil structure as wt-aSyn (Fig. 4), which was an unantici-
pated result comparing to that of aSyn(4C) protein in our previous
work [27]. The oxidative-folded mutation of a-synuclein with two
disulﬁdes [aSyn(2SS)] showed an a-helical structure because of
two disulﬁde bonds in the N-terminus and central region of the
protein [27]. Though aSyn(3SS) could have more complex inter-
disulﬁde bridges, their overall structures remained as random coil,
suggesting that the C-terminal interactions with other regions
might maintain aSyn as a natively unfolded protein. This notion
is supported by Bertoncini et al. [26] who recently reported that
long-range intra-molecular interactions between the C-terminaltail (residues 120–140) and the central part of aSyn (residues
30–100) stabilize monomeric aSyn and inhibit oligomerization
and aggregation.
3.3. Fibrillation features of X-isomers
Time course of the ﬁbrillation of wt-aSyn and X-isomers was
monitored using ThT ﬂuorescence. ThT is a widely used ﬂuores-
cence dye to detect protein ﬁbrillation [29,30], because its ﬂuores-
cence emission increases proportionally to the amount of bound
amyloid ﬁbrils. Wt-aSyn incubation exhibited a typical sigmoid
curve, indicating the formation of amyloid ﬁbrils, whereas all X-
isomers showed no change in ﬂuorescence density, suggesting no
occurrence of ﬁbrillation (Fig. 5A). To obtain insight into the struc-
tural stability of X-isomers, seeding experiments were conducted.
We incubated X-isomers with wt-aSyn, which served as the seed
material. Although wt-aSyn formed amyloid ﬁbrils after several
hours, the addition of seeds (sonicated aSyn ﬁbrils) accelerated
ﬁbrillation substantially and abolished the lag (Fig. 5B). In the case
of X-isomers, however, no ﬂuorescence increase was observed.
These results indicate that the three intra-disulﬁde bonds in aSyn
might completely inhibit inter-molecular interactions, which is an
initial step for aSyn oligomerization or ﬁbrillation. Recently, there
have been several reports on the inhibition of aggregation and
ﬁbrillation of aSyn [35–43]. Dopamine and related catecholamines
have been shown to inhibit aSyn aggregation [35,39]. Additionally,
ﬂavonoid baicalein and 4-hydroxy-2-nonenal markedly inhibited
aSyn ﬁbrillation [37,40,42]. Even the molecular chaperone heat
shock protein 70 was reported to strongly inhibit aSyn ﬁbrillation
[43]. The inhibitory activity of dopamine, baicalein and 4-hydroxy-
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oligomers of aSyn.
We also examined the ﬁbrillation of X-isomers after one-week
incubation with SDS page and Western Blot in order to detect any
oligomers or large aggregates. The incubated X-isomers were cen-
trifuged to eliminate amyloid-like aggregates and the supernatant
was collected. The supernatants of X-isomers contained most of
the proteins, suggesting they did not form aggregates. Western blot
analysis indicated that only the monomeric form existed in thesupernatants, suggesting that the monomeric form of X-isomers
may be stabilized by the formation of disulﬁde bonds between
C-terminus and N-terminus or central region (Fig. 6). The self-asso-
ciation of protein molecules followed by speciﬁc inter-molecular
D.-P. Hong et al. / FEBS Letters 585 (2011) 561–566 565interactions is a major step for protein ﬁbrillation. The X-isomers
had similar random coil structures as wt-aSyn, but it seemed that
the ﬁxed structure of X-isomers prevented the self-association of
proteins. The shorter elution time of X-isomers suggested that X-
isomers are more hydrophilic than wt-aSyn and therefore demon-
strate weaker hydrophobic interactions among X-isomers. How-
ever, this still does not explain the stability of aSyn(3SS)-isomers
because the aSyn(2SS)-isomers, with two disulﬁde bonds formed
in the N-terminal and central region, showed similar hydrophilicity
as aSyn(3SS)-isomers, but more aggregating and ﬁbrillating fea-
tures. These data suggest that C-terminus of aSyn plays a crucial
role in aSyn aggregation and ﬁbrillation.4. Discussion
4.1. The role of C-terminus on the structure of aSyn
Although aSyn is a natively unfolded protein, it is not a com-
pletely structure-free random coil. Small angle X-ray scattering
analysis showed that the gyration radius of native aSyn is 40 Å,
which is much larger than the value of folded globular protein of
similar size (15 Å), but is noticeably smaller than the radius of gyra-
tion of a fully unfolded random coil with a similar molecular mass
(52 Å) [44]. Molecular dynamics simulations also showed that
native state of aSyn is composed of an ensemble of structures that,
on average, is more compact than a random coil [45], suggesting the
existence of certain long-range interaction. NMR studies revealed
the evidence of the long-range interaction between C-terminus
and central region which was proposed to serve as an auto-inhibi-
tor of aSyn ﬁbrillation since the loss of interaction effectively pro-
moted native aSyn aggregation [26]. The C-terminus of aSyn is
negatively charged. When the C-terminus was neutralized by cal-
cium binding, the aggregation or ﬁbrillation of aSyn was acceler-
ated due to the charge shielding effect [46,47], suggesting that
the electrostatic interactions between the negative charged C-ter-
minus and the acidic N-terminus might inhibit the formation of
ﬁbrils. For instance, the truncated aSyn (1–108) with removed
C-terminus ﬁbrillates much faster than the full length aSyn
[48].The C-terminal-truncated proteins, however, could not assem-
ble into mature ﬁbrils [22]. These studies suggest that the C-termi-
nal region plays a key role in the interaction between two
protoﬁbrils. Furthermore, a hydrophobic cluster was found at the
C-terminus of aSyn and it was shown to be stabilized by long-range
interaction as well [26]. Zhou et al. [49] also demonstrated that
auto-inhibitory intra-molecular long-range interactions with C-ter-
minal methionine oxidation stabilize non-toxic oligomers of aSyn.
All these reports are consistent with our results which demon-
strated that the X-isomers aSyn(3SS) retain an unfolded structure
like that of the natively unfolded aSyn (Fig. 4), and they do not have
aggregating or ﬁbrillating features (Fig. 5). Based on all these stud-
ies, we conclude that the interactions between C-terminal and
N-terminal or central NAC region maintain the stable natively
unfolded structure of aSyn, and consequently prevent aSyn from
changing to intermediate conformations, which are required for
aggregation and ﬁbrillation. The ﬁndings from our studies, revealed
a novel role for aSyn C-terminus: a self-chaperone in the aSynmol-
ecule to maintain monomeric form before the N-terminal or central
region obtains speciﬁc structures to display its function by interact-
ing with other materials, such as lipids or proteins.
4.2. Biomedical application of aSyn X-isomers to disease treatment
It is now recognized that natively unfolded structure of protein
is an abundant phenomenon. In fact, many proteins were shown to
contain regions of disorder or even to be entirely disordered.Bioinformatics studies indicate that about 25–30% of eukaryotic
proteins are mostly disordered, that more than half of eukaryotic
proteins have long regions of disorder [50], and that more than
70% of signaling proteins have long disordered regions [51]. A
number of human diseases, including amyloidoses and several
neurodegenerative disorders originate from natively unfolded pro-
teins or peptides. In vitro, it is hard to characterize intra-molecular
interactions because they do not have a speciﬁc structure but they
are heterogeneous in structural features. Utilization of mutations
of non-native X-isomers for studying inter-molecular interactions
is thus a useful alternative. We also propose that the non-native
X-isomers could be useful for disease treatment and diagnosis.
The structure of X-isomer might differ from that of native protein
and represent a static structure of one of heterogeneous conforma-
tions of the native protein. Due to immune tolerance, native
proteins are usually not immunogenic. However, enhanced immu-
nogenicity would be expected after structural change, which was
testiﬁed in one of our studies [52]. Since extensively unfolded
X-isomers of relevant proteins can be systematically produced by
the method of disulﬁde scrambling, they can be customarily pre-
pared to test for immunogenicity and the ability to break immune
tolerance. X-isomers are thus potentially a vast resource of com-
pounds to be developed as effective immunogens and therapeutic
vaccines. For conformational diseases in general, the pathogenic
nature of deformed proteins lies in the exposure of structural ele-
ments and epitopes that are buried in the folded protein [31]. Some
exposed epitopes of denatured isomers participating in disease
development may be presented by X-isomers. In this case, antibod-
ies raised against X-isomers of disease associated proteins can be
used as diagnostic or therapeutic agents.Acknowledgements
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